Skip to main content
Erschienen in: Journal of Nuclear Cardiology 1/2011

01.02.2011 | Original Article

Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging

verfasst von: Koichi Okuda, MS, Kenichi Nakajima, MD, Tetsuo Hosoya, Takehiro Ishikawa, MS, Takahiro Konishi, NMT, Kosuke Matsubara, PhD, Shinro Matsuo, MD, Seigo Kinuya, MD

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

We have developed novel software for semi-automatically measuring heart-to-mediastinum (H/M) ratio in cardiac Iodine-123 (123I)-labeled meta-iodobenzylguanidine (MIBG) imaging. Our aim is to improve the reproducibility of the H/M ratio using the semi-automated method as opposed to the manual method.

Methods and Results

The software algorithm automatically determined the mediastinal region of interest (ROI) using information from 123I-MIBG uptake of the heart, lung, liver, and thyroid after a cardiac circular ROI was manually set. A total of 37 patients who underwent both early and delayed 123I-MIBG imaging was retrospectively selected. The heart-to-mediastinum (H/M) ratios were calculated by both semi-automated and manual methods and assessed for the intra- and inter-observer variability. All H/M ratios were classified into three groups: normal, slight abnormality, and severe abnormality. The H/M ratios with the new method were higher than those obtained manually (P<.001). In the test-retest reliability, the intra-class correlation coefficient from the semi-automated method showed excellent reproducibility for early (0.99) and delayed (0.99) imaging. The Bland-Altman plots demonstrated better agreement using the semi-automated method (a range of 95% limits −0.11 to 0.10) than that in the manual method (−0.34 to 0.27). The inter-observer agreement was also good using the semi-automated method (κ = 0.866).

Conclusions

The H/M ratio using the semi-automated method showed high reproducibility in both early and delayed imaging.
Literatur
1.
Zurück zum Zitat Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471-7.PubMed Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471-7.PubMed
2.
Zurück zum Zitat Nakata T, Miyamoto K, Doi A, Sasao H, Wakabayashi T, Kobayashi H, et al. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol 1998;5:579-90.CrossRefPubMed Nakata T, Miyamoto K, Doi A, Sasao H, Wakabayashi T, Kobayashi H, et al. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol 1998;5:579-90.CrossRefPubMed
3.
Zurück zum Zitat Yamashina S, Yamazaki J. Neuronal imaging using SPECT. Eur J Nucl Med Mol Imaging 2007;34:939-50.CrossRefPubMed Yamashina S, Yamazaki J. Neuronal imaging using SPECT. Eur J Nucl Med Mol Imaging 2007;34:939-50.CrossRefPubMed
4.
Zurück zum Zitat Agostini D, Verberne HJ, Burchert W, Knuuti J, Povinec P, Sambuceti G, et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: Insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging 2008;35:535-46.CrossRefPubMed Agostini D, Verberne HJ, Burchert W, Knuuti J, Povinec P, Sambuceti G, et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: Insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging 2008;35:535-46.CrossRefPubMed
5.
Zurück zum Zitat Jacobson AF, Lombard J, Banerjee G, Camici PG. 123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: Design of two prospective multicenter international trials. J Nucl Cardiol 2009;16:113-21.CrossRefPubMed Jacobson AF, Lombard J, Banerjee G, Camici PG. 123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: Design of two prospective multicenter international trials. J Nucl Cardiol 2009;16:113-21.CrossRefPubMed
6.
Zurück zum Zitat Parthenakis FI, Prassopoulos VK, Koukouraki SI, Zacharis EA, Diakakis GF, Karkavitsas NK, et al. Segmental pattern of myocardial sympathetic denervation in idiopathic dilated cardiomyopathy: Relationship to regional wall motion and myocardial perfusion abnormalities. J Nucl Cardiol 2002;9:15-22.CrossRefPubMed Parthenakis FI, Prassopoulos VK, Koukouraki SI, Zacharis EA, Diakakis GF, Karkavitsas NK, et al. Segmental pattern of myocardial sympathetic denervation in idiopathic dilated cardiomyopathy: Relationship to regional wall motion and myocardial perfusion abnormalities. J Nucl Cardiol 2002;9:15-22.CrossRefPubMed
7.
Zurück zum Zitat Estorch M, Camacho V, Paredes P, Rivera E, Rodriguez-Revuelto A, Flotats A, et al. Cardiac 123I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life. Eur J Nucl Med Mol Imaging 2008;35:1636-41.CrossRefPubMed Estorch M, Camacho V, Paredes P, Rivera E, Rodriguez-Revuelto A, Flotats A, et al. Cardiac 123I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life. Eur J Nucl Med Mol Imaging 2008;35:1636-41.CrossRefPubMed
8.
Zurück zum Zitat Nakajima K, Yoshita M, Matsuo S, Taki J, Kinuya S. Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders. Q J Nucl Med Mol Imaging 2008;52:378-87.PubMed Nakajima K, Yoshita M, Matsuo S, Taki J, Kinuya S. Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders. Q J Nucl Med Mol Imaging 2008;52:378-87.PubMed
9.
Zurück zum Zitat Matsuo S, Nakajima K, Yamashina S, Sakata K, Momose M, Hashimoto J, et al. Characterization of Japanese standards for myocardial sympathetic and metabolic imaging in comparison with perfusion imaging. Ann Nucl Med 2009;23:517-22.CrossRefPubMed Matsuo S, Nakajima K, Yamashina S, Sakata K, Momose M, Hashimoto J, et al. Characterization of Japanese standards for myocardial sympathetic and metabolic imaging in comparison with perfusion imaging. Ann Nucl Med 2009;23:517-22.CrossRefPubMed
10.
Zurück zum Zitat Nakajima K. Normal values for nuclear cardiology: Japanese databases for myocardial perfusion, fatty acid and sympathetic imaging and left ventricular function. Ann Nucl Med 2010;24:125-35.CrossRefPubMed Nakajima K. Normal values for nuclear cardiology: Japanese databases for myocardial perfusion, fatty acid and sympathetic imaging and left ventricular function. Ann Nucl Med 2010;24:125-35.CrossRefPubMed
11.
Zurück zum Zitat Richalet JP, Merlet P, Bourguignon M, Le-Trong JL, Keromes A, Rathat C, et al. MIBG scintigraphic assessment of cardiac adrenergic activity in response to altitude hypoxia. J Nucl Med 1990;31:34-7.PubMed Richalet JP, Merlet P, Bourguignon M, Le-Trong JL, Keromes A, Rathat C, et al. MIBG scintigraphic assessment of cardiac adrenergic activity in response to altitude hypoxia. J Nucl Med 1990;31:34-7.PubMed
12.
Zurück zum Zitat Verberne HJ, Habraken JB, van Eck-Smit BL, Agostini D, Jacobson AF. Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: A need for standardisation and validation. Eur J Nucl Med Mol Imaging 2008;35:547-53.CrossRefPubMed Verberne HJ, Habraken JB, van Eck-Smit BL, Agostini D, Jacobson AF. Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: A need for standardisation and validation. Eur J Nucl Med Mol Imaging 2008;35:547-53.CrossRefPubMed
13.
Zurück zum Zitat Nakajima K, Taki J, Tonami N, Hisada K. Decreased 123I-MIBG uptake and increased clearance in various cardiac diseases. Nucl Med Commun 1994;15:317-23.CrossRefPubMed Nakajima K, Taki J, Tonami N, Hisada K. Decreased 123I-MIBG uptake and increased clearance in various cardiac diseases. Nucl Med Commun 1994;15:317-23.CrossRefPubMed
14.
Zurück zum Zitat Chen J, Garcia EV, Galt JR, Folks RD, Carrio I. Optimized acquisition and processing protocols for I-123 cardiac SPECT imaging. J Nucl Cardiol 2006;13:251-60.PubMed Chen J, Garcia EV, Galt JR, Folks RD, Carrio I. Optimized acquisition and processing protocols for I-123 cardiac SPECT imaging. J Nucl Cardiol 2006;13:251-60.PubMed
15.
Zurück zum Zitat van der Veen L, Scholte A, Stokkel M. Mathematical methods to determine quantitative parameters of myocardial 123I-MIBG studies: A review of the literature. Nucl Med Commun 2010;31:617-28.PubMed van der Veen L, Scholte A, Stokkel M. Mathematical methods to determine quantitative parameters of myocardial 123I-MIBG studies: A review of the literature. Nucl Med Commun 2010;31:617-28.PubMed
16.
Zurück zum Zitat Motomura N, Ichihara T, Takayama T, Aoki S, Kubo H, Takeda K. Practical compensation method of downscattered component due to high energy photon in 123I imaging. Kaku Igaku 1999;36:997-1005.PubMed Motomura N, Ichihara T, Takayama T, Aoki S, Kubo H, Takeda K. Practical compensation method of downscattered component due to high energy photon in 123I imaging. Kaku Igaku 1999;36:997-1005.PubMed
17.
Zurück zum Zitat Matsuo S, Nakajima K, Okuda K, Kawano M, Ishikawa T, Hosoya T, et al. Standardization of the heart-to-mediastinum ratio of 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: Feasibility of correction with different camera-collimator combinations. Eur J Nucl Med Mol Imaging 2009;36:560-6.CrossRefPubMed Matsuo S, Nakajima K, Okuda K, Kawano M, Ishikawa T, Hosoya T, et al. Standardization of the heart-to-mediastinum ratio of 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: Feasibility of correction with different camera-collimator combinations. Eur J Nucl Med Mol Imaging 2009;36:560-6.CrossRefPubMed
18.
Zurück zum Zitat Yamashina S, Yamazaki J. Role of MIBG myocardial scintigraphy in the assessment of heart failure: The need to establish evidence. Eur J Nucl Med Mol Imaging 2004;31:1353-5.CrossRefPubMed Yamashina S, Yamazaki J. Role of MIBG myocardial scintigraphy in the assessment of heart failure: The need to establish evidence. Eur J Nucl Med Mol Imaging 2004;31:1353-5.CrossRefPubMed
19.
Zurück zum Zitat Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.PubMed Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.PubMed
20.
Zurück zum Zitat Bland JM, Altman DG. Measurement error proportional to the mean. BMJ 1996;313:106.PubMed Bland JM, Altman DG. Measurement error proportional to the mean. BMJ 1996;313:106.PubMed
21.
Zurück zum Zitat Morozumi T, Kusuoka H, Fukuchi K, Tani A, Uehara T, Matsuda S, et al. Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med 1997;38:49-52.PubMed Morozumi T, Kusuoka H, Fukuchi K, Tani A, Uehara T, Matsuda S, et al. Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med 1997;38:49-52.PubMed
22.
Zurück zum Zitat Somsen GA, Verberne HJ, Fleury E, Righetti A. Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: Implications for clinical studies. J Nucl Cardiol 2004;11:126-33.CrossRefPubMed Somsen GA, Verberne HJ, Fleury E, Righetti A. Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: Implications for clinical studies. J Nucl Cardiol 2004;11:126-33.CrossRefPubMed
23.
Zurück zum Zitat Nishimura T, Sugishita Y, Sasaki Y. The results of questionnaire on quantitative assessment of 123I-metaiodobenzylguanidine myocardial scintigraphy in heart failure. Kaku Igaku 1997;34:1139-48.PubMed Nishimura T, Sugishita Y, Sasaki Y. The results of questionnaire on quantitative assessment of 123I-metaiodobenzylguanidine myocardial scintigraphy in heart failure. Kaku Igaku 1997;34:1139-48.PubMed
Metadaten
Titel
Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging
verfasst von
Koichi Okuda, MS
Kenichi Nakajima, MD
Tetsuo Hosoya
Takehiro Ishikawa, MS
Takahiro Konishi, NMT
Kosuke Matsubara, PhD
Shinro Matsuo, MD
Seigo Kinuya, MD
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 1/2011
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-010-9313-4

Weitere Artikel der Ausgabe 1/2011

Journal of Nuclear Cardiology 1/2011 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.